PURPOSE: To retrospectively review an institutional experience in managing atypical teratoid/rhabdoid tumors (AT/RT) of the Central Nervous System with high-dose chemotherapy in infants and children less than 4 years old. MATERIALS/ METHODS: Eight AT/RT patients were identified during the study period 2003 to 2008. Tumor location was supratentorial in 3 cases, infratentorial in 3 cases, and multifocal in 2 patients. Five patients presented with leptomeningeal dissemination. Two of these patients did not receive any active therapy. After surgery, the 6 remaining patients received induction therapy followed by sequential high-dose chemotherapy with autologous stem cell rescue. Two patients receive focal irradiation. RESULTS: At a median follow-up of 52 months, 4 patients are alive without evidence of tumor. Three of these patients, including 2 with metastatic disease were not irradiated. However, all surviving patients exhibit neuro-cognitive impairment, either at baseline assessment or upon follow-up. CONCLUSIONS: This experience confirms that a subset of young AT/RT patients may achieve long-term survival with intensive and high-dose chemotherapy. The role of radiotherapy is still unclear. However, evidence of neuro-cognitive impairment even in the absence of radiotherapy in this young population suggests that systematic introduction of radiotherapy in current protocols should be carefully assessed.
PURPOSE: To retrospectively review an institutional experience in managing atypical teratoid/rhabdoid tumors (AT/RT) of the Central Nervous System with high-dose chemotherapy in infants and children less than 4 years old. MATERIALS/ METHODS: Eight AT/RT patients were identified during the study period 2003 to 2008. Tumor location was supratentorial in 3 cases, infratentorial in 3 cases, and multifocal in 2 patients. Five patients presented with leptomeningeal dissemination. Two of these patients did not receive any active therapy. After surgery, the 6 remaining patients received induction therapy followed by sequential high-dose chemotherapy with autologous stem cell rescue. Two patients receive focal irradiation. RESULTS: At a median follow-up of 52 months, 4 patients are alive without evidence of tumor. Three of these patients, including 2 with metastatic disease were not irradiated. However, all surviving patients exhibit neuro-cognitive impairment, either at baseline assessment or upon follow-up. CONCLUSIONS: This experience confirms that a subset of young AT/RT patients may achieve long-term survival with intensive and high-dose chemotherapy. The role of radiotherapy is still unclear. However, evidence of neuro-cognitive impairment even in the absence of radiotherapy in this young population suggests that systematic introduction of radiotherapy in current protocols should be carefully assessed.
Authors: Vivek Verma; Catrina P Johnson; Nathan R Bennion; Abhijeet R Bhirud; Sicong Li; Rodney D McComb; Chi Lin Journal: Childs Nerv Syst Date: 2015-05-05 Impact factor: 1.475
Authors: Michael C Frühwald; Jaclyn A Biegel; Franck Bourdeaut; Charles W M Roberts; Susan N Chi Journal: Neuro Oncol Date: 2016-01-10 Impact factor: 12.300
Authors: M Benesch; K Bartelheim; G Fleischhack; B Gruhn; P G Schlegel; O Witt; K D Stachel; H Hauch; C Urban; F Quehenberger; M Massimino; T Pietsch; M Hasselblatt; F Giangaspero; U Kordes; R Schneppenheim; P Hauser; T Klingebiel; M C Frühwald Journal: Bone Marrow Transplant Date: 2014-01-13 Impact factor: 5.483
Authors: Alyssa T Reddy; Douglas R Strother; Alexander R Judkins; Peter C Burger; Ian F Pollack; Mark D Krailo; Allen B Buxton; Chris Williams-Hughes; Maryam Fouladi; Anita Mahajan; Thomas E Merchant; Ben Ho; Claire M Mazewski; Victor A Lewis; Amar Gajjar; Louis-Gilbert Vezina; Timothy N Booth; Kerry W Parsons; Vicky L Poss; Tianni Zhou; Jaclyn A Biegel; Annie Huang Journal: J Clin Oncol Date: 2020-02-27 Impact factor: 44.544
Authors: Chantel Cacciotti; Muhammad Ali; Ute Bartels; Jonathan D Wasserman; Erilda Kapllani; Joerg Krueger; Eric Bouffet; Tal Schechter Journal: Childs Nerv Syst Date: 2020-11-18 Impact factor: 1.475
Authors: Min Yang; Xi Chen; Ning Wang; Kun Zhu; Ying-Zi Hu; Yun Zhao; Yan Shu; Man-Li Zhao; Wei-Zhong Gu; Hong-Feng Tang Journal: Int J Clin Exp Pathol Date: 2014-04-15
Authors: Viktor Arnhold; Florian Oyen; Reinhard Schneppenheim; Hannes Haberl; Arend Koch; Michael C Frühwald; Pablo Hernáiz Driever Journal: Childs Nerv Syst Date: 2016-01-08 Impact factor: 1.475